Nashville, TN, United States of America

Sydney Spector

This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 1996-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 1.3

ph-index = 1

Forward Citations = 50(Granted Patents)


Company Filing History:

goldMedal2 out of 834,411 
Other
 patents

Years Active: 1996-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sydney Spector: Innovator in Medical Treatments

Introduction

Sydney Spector is a notable inventor based in Nashville, TN (US). She has made significant contributions to the field of medical treatments, particularly in the area of cancer and opiate addiction. With a total of 2 patents, her work is paving the way for innovative solutions in healthcare.

Latest Patents

Sydney's latest patents include a compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis. This invention provides compounds of the formula (I) that could potentially revolutionize cancer treatment. Additionally, she has developed a method for treating opiate withdrawal, which discloses a way to attenuate the withdrawal syndrome by administering the compound levamisole in a suitable pharmaceutical carrier.

Career Highlights

Throughout her career, Sydney has focused on creating effective treatments that address critical health issues. Her dedication to research and innovation has led to the development of groundbreaking methods that can improve patient outcomes.

Collaborations

Sydney collaborates with her coworker, Neil Lee Spector, to further enhance her research and development efforts. Together, they work on advancing medical treatments that can significantly impact the lives of individuals suffering from various health conditions.

Conclusion

Sydney Spector is a pioneering inventor whose work in medical treatments is making a difference in the healthcare industry. Her innovative patents reflect her commitment to improving patient care and addressing pressing health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…